[1] DR SIMON D. BRANDT. Analysis of NRG ‘legal highs’ in the UK: identification and formation of novel cathinones[J]. Drug Testing and Analysis, 2010, 3 9: 569-575. DOI:
10.1002/dta.204[2] FOLKER WESTPHAL . Mass spectral and NMR spectral data of two new designer drugs with an α-aminophenone structure: 4′-Methyl-α-pyrrolidinohexanophenone and 4′-methyl-α-pyrrolidinobutyrophenone[J]. Forensic science international, 2007, 169 1: Pages 32-42. DOI:
10.1016/j.forsciint.2006.07.024[3] MARKUS R MEYER Hans H M. Metabolism of designer drugs of abuse: an updated review.[J]. Current drug metabolism, 2010, 11 5: 468-482. DOI:
10.2174/138920010791526042[4] FRANK T PETERS. Identification of cytochrome P450 enzymes involved in the metabolism of the new designer drug 4’-methyl-alpha-pyrrolidinobutyrophenone.[J]. Drug Metabolism and Disposition, 2008, 36 1: 163-168. DOI:
10.1124/dmd.107.017293[5] STEPHANIE CARNES. Comparison of ultra high performance supercritical fluid chromatography, ultra high performance liquid chromatography, and gas chromatography for the separation of synthetic cathinones[J]. Journal of separation science, 2017, 40 17: 3545-3556. DOI:
10.1002/jssc.201700349